Exact Sciences Corporation struggles with profitability due to high expenses. See why EXAS stock faces challenges despite the ...

In the test that secured its approval, Cologuard Plus had a sensitivity of 95% and specificity of 94% in people with average ...

In a trial of 19,000 patients, the Cologuard Plus test demonstrated 95% overall cancer sensitivity and 43% sensitivity for advanced precancerous lesions at 94% specificity. "Colonoscopy is still the ...

Cologuard is the best screening test ever developed and widely adopted in the U.S. in terms of performance, sensitivity, and specificity. The sensitivity of Cologuard, 92% specificity 90%.

Cologuard refers to an at-home stool DNA test that can help screen for colon cancer or polyps. A person enrolled in Medicare aged between 45 and 85 is eligible for coverage for a Cologuard test ...

Here are 10 breakthroughs for GI physicians and leaders to know: 1. The American Gastroenterological Association recently updated guidance for the treatment of ulcerative colitis to recommend using ...

Alert FDA OKs Next-Gen Cologuard ... Test for CRC Screening In average-risk adults, Cologuard Plus demonstrated sensitivities of 95% for CRC and 43% for advanced precancerous lesions at 94% ...